Chemo Experts, the easiest way to learn about cancer treatment
Find a Treatment:
Cancer Types

Treatment Name: Cisplatin + Docetaxel (Taxotere®)

Cisplatin + Docetaxel (Taxotere®) is a Chemotherapy Regimen for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)

Thank you for visiting our Cisplatin + Docetaxel (Taxotere®) page.

  • If you are interested in seeing the full treatment regimen page for Cisplatin + Docetaxel (Taxotere®) sooner rather than later, please cast your vote for Cisplatin + Docetaxel (Taxotere®).
  • Votes from users like you are important as they help us prioritize the order in which we build our content. The more requests we receive, the faster we will build it!

While we work on uploading the pages that matter to you most, we hope that links to journal article references for Cisplatin + Docetaxel (Taxotere®) shown below will prove useful in the meantime.

Thank you for your continued support!

The ChemoExperts Team


1) Fossella F, Periera JR, von Pawel J, et al. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol. 2003;21:3016-3024.

Created: March 12, 2019 Updated: March 12, 2019

What is Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)?

What is Non-Small Cell Lung Cancer?
A disease of the tissue found in the lung.  Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Known causes include smoking and exposure to environmental toxins.  The stage of NSCLC can vary at diagnosis and throughout treatment.  Stages include stage I, II, III, and IV.  The effectiveness of the treatment may depend upon the stage at diagnosis.

NOTE: Treatment Options listed below are not all-inclusive. Other treatments may be available. ChemoExperts provides drug information and does not recommend any one treatment over another. Only your Doctor can choose which therapy is appropriate for you.

Common Cisplatin + Docetaxcel starting doses

  • Cisplatin 75 mg/m2 intravenous (I.V.) infusion over 60 minutes on Day 1
  • Docetaxel 75 mg/m2 I.V. infusion over 60 minutes on Day 1